$215.48
0[0.00%]
At close: Apr 22
$215.48
0[0.00%]
PreMarket: 4:20PM EDT
CME Gr Stock (NASDAQ:CME), Analyst Ratings, Price Targets, Predictions
CME Group Inc has a consensus price target of $215.87, established from looking at the 90 latest analyst ratings. The last 3 analyst ratings were released from Morgan Stanley, Barclays, and Deutsche Bank on April 9, 2024, April 8, 2024, and April 5, 2024. With an average price target of $220.33 between Morgan Stanley, Barclays, and Deutsche Bank, there's an implied 2.25% upside for CME Group Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Barclays
Deutsche Bank
Keefe, Bruyette & Woods
Argus Research
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for CME Gr
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/09/2024 | CME | Buy Now | CME Gr | $215.48 | 4.42% | Morgan Stanley | Mike Cyprys | $222 → $225 | Maintains | Equal-Weight | Get Alert |
| 04/08/2024 | CME | Buy Now | CME Gr | $215.48 | 4.88% | Barclays | Benjamin Budish | $225 → $226 | Maintains | Equal-Weight | Get Alert |
| 04/05/2024 | CME | Buy Now | CME Gr | $215.48 | -2.54% | Deutsche Bank | Brian Bedell | $235 → $210 | Downgrade | Buy → Hold | Get Alert |
| 04/03/2024 | CME | Buy Now | CME Gr | $215.48 | 6.27% | Keefe, Bruyette & Woods | Kyle Voigt | → $229 | Maintains | Market Perform | Get Alert |
| 03/06/2024 | CME | Buy Now | CME Gr | $215.48 | 13.7% | Argus Research | Kevin Heal | $225 → $245 | Maintains | Buy | Get Alert |
| 02/15/2024 | CME | Buy Now | CME Gr | $215.48 | 4.42% | Barclays | Benjamin Budish | $222 → $225 | Maintains | Equal-Weight | Get Alert |
| 01/08/2024 | CME | Buy Now | CME Gr | $215.48 | 3.03% | Barclays | Benjamin Budish | $244 → $222 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/04/2024 | CME | Buy Now | CME Gr | $215.48 | -16.47% | Rosenblatt | Andrew Bond | → $180 | Reiterates | Sell → Sell | Get Alert |
| 01/03/2024 | CME | Buy Now | CME Gr | $215.48 | -9.5% | Goldman Sachs | Alexander Blostein | → $195 | Downgrade | Neutral → Sell | Get Alert |
| 10/26/2023 | CME | Buy Now | CME Gr | $215.48 | 13.24% | Barclays | Benjamin Budish | $247 → $244 | Maintains | Overweight | Get Alert |
| 10/26/2023 | CME | Buy Now | CME Gr | $215.48 | 2.1% | Morgan Stanley | Mike Cyprys | $215 → $220 | Maintains | Equal-Weight | Get Alert |
| 10/26/2023 | CME | Buy Now | CME Gr | $215.48 | -16.47% | Rosenblatt | Andrew Bond | $173 → $180 | Maintains | Sell | Get Alert |
| 10/12/2023 | CME | Buy Now | CME Gr | $215.48 | 11.38% | Citigroup | Christopher Allen | $215 → $240 | Maintains | Buy | Get Alert |
| 10/11/2023 | CME | Buy Now | CME Gr | $215.48 | -8.58% | JP Morgan | Kenneth Billingsley | $190 → $197 | Maintains | Neutral | Get Alert |
| 10/11/2023 | CME | Buy Now | CME Gr | $215.48 | -0.22% | Morgan Stanley | Mike Cyprys | $211 → $215 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | CME | Buy Now | CME Gr | $215.48 | 11.38% | Deutsche Bank | Brian Bedell | $224 → $240 | Maintains | Buy | Get Alert |
| 10/10/2023 | CME | Buy Now | CME Gr | $215.48 | 14.63% | Barclays | Benjamin Budish | $230 → $247 | Maintains | Overweight | Get Alert |
| 10/04/2023 | CME | Buy Now | CME Gr | $215.48 | -19.71% | Rosenblatt | Andrew Bond | → $173 | Reiterates | Sell → Sell | Get Alert |
| 09/06/2023 | CME | Buy Now | CME Gr | $215.48 | -5.33% | B of A Securities | Craig Siegenthaler | $167 → $204 | Upgrade | Underperform → Neutral | Get Alert |
FAQ
What is the target price for CME Gr (CME)?
The latest price target for CME Gr (NASDAQ: CME) was reported by Morgan Stanley on April 9, 2024. The analyst firm set a price target for $225.00 expecting CME to rise to within 12 months (a possible 4.42% upside). 29 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CME Gr (CME)?
The latest analyst rating for CME Gr (NASDAQ: CME) was provided by Morgan Stanley, and CME Gr maintained their equal-weight rating.
When was the last upgrade for CME Gr (CME)?
The last upgrade for CME Group Inc happened on September 6, 2023 when B of A Securities raised their price target to $204. B of A Securities previously had an underperform for CME Group Inc.
When was the last downgrade for CME Gr (CME)?
The last downgrade for CME Group Inc happened on April 5, 2024 when Deutsche Bank changed their price target from $235 to $210 for CME Group Inc.
When is the next analyst rating going to be posted or updated for CME Gr (CME)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CME Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CME Gr was filed on April 9, 2024 so you should expect the next rating to be made available sometime around April 9, 2025.
Is the Analyst Rating CME Gr (CME) correct?
While ratings are subjective and will change, the latest CME Gr (CME) rating was a maintained with a price target of $222.00 to $225.00. The current price CME Gr (CME) is trading at is $215.48, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.